An HX - Search Results

1

Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer.

Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, Hinzmann B, Kristiansen G, Grützmann R, Kuner R, Petschke B, Rhiem K, Wiechen K, Sers C, Wiestler O, Schneider A, Höfler H, Nährig J, Dietel M, Schäfer R, Rosenthal A, Schmutzler R, Dürst M, Meindl A, Niederacher D. Dahl E, et al. Among authors: an hx. J Pathol. 2005 Jan;205(1):21-8. doi: 10.1002/path.1687. J Pathol. 2005. PMID: 15586368

2

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.

Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Dürst M, Kristiansen G, Huszka C, Knüchel R, Dahl E. Veeck J, et al. Oncogene. 2006 Jun 8;25(24):3479-88. doi: 10.1038/sj.onc.1209386. Epub 2006 Jan 30. Oncogene. 2006. PMID: 16449975

3

[Epigenetic inactivation of the WNT antagonist SFRP1 in breast cancer].

Dahl E, Veeck J, An H, Wiesmann F, Klopocki E, Sauter G, Kristiansen G, Hartmann A, Knüchel R. Dahl E, et al. Verh Dtsch Ges Pathol. 2005;89:169-77. Verh Dtsch Ges Pathol. 2005. PMID: 18035687 German.

4

Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.

An HX, Beckmann MW, Reifenberger G, Bender HG, Niederacher D. An HX, et al. Am J Pathol. 1999 Jan;154(1):113-8. doi: 10.1016/S0002-9440(10)65257-1. Am J Pathol. 1999. PMID: 9916925 Free PMC article.

5

Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer.

You A, Fokas E, Wang LF, He H, Kleb B, Niederacher D, Engenhart-Cabillic R, An HX. You A, et al. Among authors: an hx. J Cancer Res Clin Oncol. 2011 Apr;137(4):621-7. doi: 10.1007/s00432-010-0916-6. Epub 2010 Jun 9. J Cancer Res Clin Oncol. 2011. PMID: 20532910

6

CDKN2A gene inactivation in epithelial sporadic ovarian cancer.

Niederacher D, Yan HY, An HX, Bender HG, Beckmann MW. Niederacher D, et al. Among authors: an hx. Br J Cancer. 1999 Aug;80(12):1920-6. doi: 10.1038/sj.bjc.6690621. Br J Cancer. 1999. PMID: 10471040 Free PMC article.

7

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.

Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW. Niederacher D, et al. Among authors: an hx. Genes Chromosomes Cancer. 1997 Mar;18(3):181-92. doi: 10.1002/(sici)1098-2264(199703)18:3<181::aid-gcc5>3.0.co;2-y. Genes Chromosomes Cancer. 1997. PMID: 9071571

8

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.

An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW. An HX, et al. Genes Chromosomes Cancer. 1996 Sep;17(1):14-20. doi: 10.1002/(SICI)1098-2264(199609)17:1<14::AID-GCC3>3.0.CO;2-5. Genes Chromosomes Cancer. 1996. PMID: 8889502

9

Detection of sequential genetic alterations relevant for breast cancer development.

Niederacher D, Schnürch HG, An HX, Ellenberger I, Dall P, van Roeyen CR, Küppers V, Beckmann MW. Niederacher D, et al. Among authors: an hx. Eur J Cancer Prev. 1996 Dec;5(6):497-503. Eur J Cancer Prev. 1996. PMID: 9061283

10

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

Beckmann MW, Picard F, An HX, van Roeyen CR, Dominik SI, Mosny DS, Schnürch HG, Bender HG, Niederacher D. Beckmann MW, et al. Among authors: an hx. Br J Cancer. 1996 May;73(10):1220-6. doi: 10.1038/bjc.1996.234. Br J Cancer. 1996. PMID: 8630282 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters